Ghent University Academic Bibliography

Advanced

In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial

Nanja van Geel UGent, Reinhart Speeckaert UGent, ILSE MOLLET UGent, Sofie De Schepper UGent, Julie De Wolf UGent, Esther PM Tjin, Rosalie M Luiten, Jo Lambert UGent and Lieve Brochez UGent (2012) PIGMENT CELL & MELANOMA RESEARCH. 25(1). p.57-65
abstract
In this study, we developed an in vivo vitiligo induction model to explore the underlying mechanisms leading to Koebner's phenomenon and to evaluate the efficacy of therapeutic strategies. The model consisted of 12 pigmented test regions on the back of generalized vitiligo patients that were exposed to three Koebner induction methods: cryotherapy, 755 nm laser therapy, and epidermal abrasion. In addition, four cream treatments (pimecrolimus, tacrolimus, steroid and placebo) were randomly applied. Koebnerization was efficiently induced by all three induction methods. In general, cryotherapy was the best method of Koebner induction, followed by 755 nm laser therapy and epidermal abrasion. Reproducible results were obtained, which showed enhanced depigmented surface areas and higher amounts of T lymphocytes in placebo-treated test zones compared to active treated areas. Tacrolimus and local steroids were better inhibitors of Koebner's process (P < 0.05) compared to pimecrolimus. Our in vivo vitiligo induction model is very informative to investigate vitiligo induction and to determine the efficacy of topical treatments in vitiligo. This proof of concept confirms the efficient comparison of head-to-head therapeutic strategies intra-individually in a standardized, specific and better timed way.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Koebner phenomenon, vitiligo, treatment, experimental model, topical immunomodulators, T-CELLS, KOEBNERS PHENOMENON, SKIN
journal title
PIGMENT CELL & MELANOMA RESEARCH
Pigment Cell Melanoma Res.
volume
25
issue
1
pages
57 - 65
Web of Science type
Article
Web of Science id
000298577600010
JCR category
DERMATOLOGY
JCR impact factor
5.839 (2012)
JCR rank
2/58 (2012)
JCR quartile
1 (2012)
ISSN
1755-1471
DOI
10.1111/j.1755-148X.2011.00922.x
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1955595
handle
http://hdl.handle.net/1854/LU-1955595
date created
2011-11-29 12:37:54
date last changed
2012-09-21 14:04:22
@article{1955595,
  abstract     = {In this study, we developed an in vivo vitiligo induction model to explore the underlying mechanisms leading to Koebner's phenomenon and to evaluate the efficacy of therapeutic strategies. The model consisted of 12 pigmented test regions on the back of generalized vitiligo patients that were exposed to three Koebner induction methods: cryotherapy, 755\hspace{1em}nm laser therapy, and epidermal abrasion. In addition, four cream treatments (pimecrolimus, tacrolimus, steroid and placebo) were randomly applied. Koebnerization was efficiently induced by all three induction methods. In general, cryotherapy was the best method of Koebner induction, followed by 755\hspace{1em}nm laser therapy and epidermal abrasion. Reproducible results were obtained, which showed enhanced depigmented surface areas and higher amounts of T lymphocytes in placebo-treated test zones compared to active treated areas. Tacrolimus and local steroids were better inhibitors of Koebner's process (P {\textlangle} 0.05) compared to pimecrolimus. Our in vivo vitiligo induction model is very informative to investigate vitiligo induction and to determine the efficacy of topical treatments in vitiligo. This proof of concept confirms the efficient comparison of head-to-head therapeutic strategies intra-individually in a standardized, specific and better timed way.},
  author       = {van Geel, Nanja and Speeckaert, Reinhart and MOLLET, ILSE and De Schepper, Sofie and De Wolf, Julie and Tjin, Esther PM and Luiten, Rosalie M and Lambert, Jo and Brochez, Lieve},
  issn         = {1755-1471},
  journal      = {PIGMENT CELL \& MELANOMA RESEARCH},
  keyword      = {Koebner phenomenon,vitiligo,treatment,experimental model,topical immunomodulators,T-CELLS,KOEBNERS PHENOMENON,SKIN},
  language     = {eng},
  number       = {1},
  pages        = {57--65},
  title        = {In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial},
  url          = {http://dx.doi.org/10.1111/j.1755-148X.2011.00922.x},
  volume       = {25},
  year         = {2012},
}

Chicago
van Geel, Nanja, Reinhart Speeckaert, ILSE MOLLET, Sofie De Schepper, Julie De Wolf, Esther PM Tjin, Rosalie M Luiten, Jo Lambert, and Lieve Brochez. 2012. “In Vivo Vitiligo Induction and Therapy Model: Double-blind, Randomized Clinical Trial.” Pigment Cell & Melanoma Research 25 (1): 57–65.
APA
van Geel, N., Speeckaert, R., MOLLET, I., De Schepper, S., De Wolf, J., Tjin, E. P., Luiten, R. M., et al. (2012). In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. PIGMENT CELL & MELANOMA RESEARCH, 25(1), 57–65.
Vancouver
1.
van Geel N, Speeckaert R, MOLLET I, De Schepper S, De Wolf J, Tjin EP, et al. In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. PIGMENT CELL & MELANOMA RESEARCH. 2012;25(1):57–65.
MLA
van Geel, Nanja, Reinhart Speeckaert, ILSE MOLLET, et al. “In Vivo Vitiligo Induction and Therapy Model: Double-blind, Randomized Clinical Trial.” PIGMENT CELL & MELANOMA RESEARCH 25.1 (2012): 57–65. Print.